Both genetic knockdown and pharmacological inhibition with HPA-12 selectively induces Cer retention in FLT3-ITD AML cells, reducing viability and promoting apoptosis while sparing FLT3 wild-type cells [110]. The gene discussed is FLT3; the disease is acute myeloid leukemia.